{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:42:42Z","timestamp":1771461762582,"version":"3.50.1"},"reference-count":101,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1721,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1111\/j.1365-2362.2010.02439.x","type":"journal-article","created":{"date-parts":[[2010,12,15]],"date-time":"2010-12-15T15:03:58Z","timestamp":1292425438000},"page":"568-578","source":"Crossref","is-referenced-by-count":16,"title":["The development of familial hypertrophic cardiomyopathy: from mutation to bedside"],"prefix":"10.1111","volume":"41","author":[{"given":"Wessel P.","family":"Brouwer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine J.","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ger J. M.","family":"Stienen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert C.","family":"van Rossum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolanda","family":"van der Velden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tjeerd","family":"Germans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,12,15]]},"reference":[{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/0735-1097(95)00390-8","article-title":"Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients","volume":"26","author":"Klues","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"513","DOI":"10.7326\/0003-4819-152-8-201004200-00008","article-title":"Narrative review: harnessing molecular genetics for the diagnosis and management of hypertrophic cardiomyopathy","volume":"152","author":"Wang","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/01.CIR.0000012626.81324.38","article-title":"Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy","volume":"105","author":"Sachdev","year":"2002","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/jama.2009.371","article-title":"Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy","volume":"301","author":"Maron","year":"2009","journal-title":"JAMA"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(00)02533-2","article-title":"Recombinant human [alpha]-glucosidase from rabbit milk in Pompe patients","volume":"356","author":"Van den Hout","year":"2000","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa033349","article-title":"Glycogen storage diseases presenting as hypertrophic cardiomyopathy","volume":"352","author":"Arad","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.jacc.2009.12.040","article-title":"Infiltrative cardiovascular diseases: cardiomyopathies that look alike","volume":"55","author":"Seward","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0140-6736(05)76188-2","article-title":"Mitochondrial DNA abnormalities in hypertrophic cardiomyopathy","volume":"353","author":"Odawara","year":"1999","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1161\/01.CIR.0000068686.12195.C2","article-title":"To screen or not is not the question - it is when and how to screen","volume":"107","author":"Marian","year":"2003","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1016\/j.jacc.2006.08.036","article-title":"Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations","volume":"48","author":"Germans","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1161\/01.CIR.104.2.128","article-title":"Tissue doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy","volume":"104","author":"Nagueh","year":"2001","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1161\/01.CIR.0000084500.72232.8D","article-title":"Tissue doppler imaging predicts the development of hypertrophic cardiomyopathy in subjects with subclinical disease","volume":"108","author":"Nagueh","year":"2003","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1161\/01.CIR.0000019070.70491.6D","article-title":"Assessment of diastolic function with doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy","volume":"105","author":"Ho","year":"2002","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jcmg.2008.08.003","article-title":"Diastolic abnormalities as the first feature of hypertrophic cardiomyopathy in Dutch myosin-binding protein C founder mutations","volume":"2","author":"Michels","year":"2009","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/eurheartj\/ehq101","article-title":"Early identification of mutation carriers in familial hypertrophic cardiomyopathy by combined echocardiography and tissue Doppler imaging","volume":"13","author":"Gandjbakhch","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1532-429X-12-13","article-title":"How do hypertrophic cardiomyopathy mutations affect myocardial function in carriers with normal wall thickness? Assessment with cardiovascular magnetic resonance","volume":"12","author":"Germans","year":"2010","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/0002-9149(92)90771-P","article-title":"Myocardial disarray at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy","volume":"70","author":"Kuribayashi","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jacc.2007.06.026","article-title":"Clefts can be seen in the basal inferior wall of the left ventricle and the interventricular septum in healthy volunteers as well as patients by cardiovascular magnetic resonance","volume":"50","author":"Johansson","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1093\/eurheartj\/ehq140","article-title":"Ventricular septal crypt in hypertrophic cardiomyopathy","volume":"15","author":"Maron","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1161\/hc3701.095952","article-title":"Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease","volume":"104","author":"Varnava","year":"2001","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"e396","DOI":"10.1161\/CIRCULATIONAHA.105.579268","article-title":"A clinician\u2019s guide to tissue doppler imaging","volume":"113","author":"Ho","year":"2006","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJMoa1002659","article-title":"Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy","volume":"363","author":"Ho","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1126\/science.1137325","article-title":"Polony multiplex analysis of gene expression (PMAGE) in mouse hypertrophic cardiomyopathy","volume":"316","author":"Kim","year":"2007","journal-title":"Science"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1056\/NEJM199804303381802","article-title":"Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy","volume":"338","author":"Niimura","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0735-1097(01)01386-9","article-title":"Development of left ventricular hypertrophy in adults with hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations","volume":"38","author":"Maron","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMoa075463","article-title":"Shared genetic causes of cardiac hypertrophy in children and adults","volume":"358","author":"Morita","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1161\/CIRCULATIONAHA.104.530303","article-title":"Clinical features and outcomes of childhood hypertrophic cardiomyopathy: results from a national population-based study","volume":"112","author":"Nugent","year":"2005","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1172\/JCI119555","article-title":"Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy. Characterization Of cardiac transcript and protein","volume":"100","author":"Rottbauer","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1161\/01.CIR.101.12.1396","article-title":"A newly created splice donor site in exon 25 of the MyBP-C gene is responsible for inherited hypertrophic cardiomyopathy with incomplete disease penetrance","volume":"101","author":"Moolman","year":"2000","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1161\/CIRCULATIONAHA.108.838672","article-title":"Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction","volume":"119","author":"van Dijk","year":"2009","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1161\/CIRCRESAHA.109.202440","article-title":"Evidence from human myectomy samples that MYBPC3 mutations cause hypertrophic cardiomyopathy through haploinsufficiency","volume":"105","author":"Marston","year":"2009","journal-title":"Circ Res"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10741-005-5253-5","article-title":"Sarcomeric proteins and familial hypertrophic cardiomyopathy: linking mutations in structural proteins to complex cardiovascular phenotypes","volume":"10","author":"Tardiff","year":"2005","journal-title":"Heart Fail Rev"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1161\/CIRCRESAHA.107.156380","article-title":"Dilated and hypertrophic cardiomyopathy mutations in Troponin and {alpha}-Tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments","volume":"101","author":"Robinson","year":"2007","journal-title":"Circ Res"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1540-8167.1998.tb00871.x","article-title":"Molecular genetic basis of hypertrophic cardiomyopathy: genetic markers for sudden cardiac death","volume":"9","author":"Marian","year":"1998","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0168-9525(03)00081-7","article-title":"Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion","volume":"19","author":"Ashrafian","year":"2003","journal-title":"Trends Genet"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/S0735-1097(02)03009-7","article-title":"Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy","volume":"41","author":"Crilley","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrm1983","article-title":"Regulation of cardiac hypertrophy by intracellular signalling pathways","volume":"7","author":"Heineke","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.phrs.2009.11.012","article-title":"Molecular targets and regulators of cardiac hypertrophy","volume":"61","author":"Rohini","year":"2010","journal-title":"Pharmacol Res"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1126\/science.281.5383.1690","article-title":"Prevention of cardiac hypertrophy in mice by calcineurin inhibition","volume":"281","author":"Sussman","year":"1998","journal-title":"Science"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1006\/jmcc.2000.1113","article-title":"Reversal of cardiac hypertrophy in transgenic disease models by calcineurin inhibition","volume":"32","author":"Lim","year":"2000","journal-title":"J Mol Cell Cardiol"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1161\/01.CIR.0000086469.85750.48","article-title":"Consequences of pressure overload on sarcomere protein mutation-induced hypertrophic cardiomyopathy","volume":"108","author":"Schmitt","year":"2003","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00001573-199707000-00005","article-title":"Mechanisms of hypertension in cardiac transplantation and the role of cyclosporine","volume":"12","author":"Ventura","year":"1997","journal-title":"Curr Opin Cardiol"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jacc.2005.10.041","article-title":"Antifibrotic effects of antioxidant N-Acetylcysteine in a mouse model of human hypertrophic cardiomyopathy mutation","volume":"47","author":"Marian","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1734-1140(09)70091-X","article-title":"Enhanced oxidative stress in hypertrophic cardiomyopathy","volume":"61","author":"Dimitrow","year":"2009","journal-title":"Pharmacol Rep"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cardfail.2004.05.005","article-title":"Relationship between oxidative stress and systolic dysfunction in patients with hypertrophic cardiomyopathy","volume":"11","author":"Nakamura","year":"2005","journal-title":"J Card Fail"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1161\/CIRCULATIONAHA.108.790501","article-title":"Resolution of established cardiac hypertrophy and fibrosis and prevention of systolic dysfunction in a transgenic rabbit model of human cardiomyopathy through thiol-sensitive mechanisms","volume":"119","author":"Lombardi","year":"2009","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/hrt.20.1.1","article-title":"Asymmetrical hypertrophy of the heart in young adults","volume":"1","author":"Teare","year":"1958","journal-title":"Br Heart J"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/0002-9149(81)90068-0","article-title":"Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients","volume":"48","author":"Maron","year":"1981","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.amjcard.2003.07.027","article-title":"Comparison of prevalence of apical hypertrophic cardiomyopathy in Japan and the United States","volume":"92","author":"Kitaoka","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.echo.2010.06.006","article-title":"Hypertrophy pattern and regional myocardial mechanics are related in septal and apical hypertrophic cardiomyopathy","volume":"10","author":"Yang","year":"2010","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1081\/JCMR-200060631","article-title":"Differentiation of athlete\u2019s heart from pathological forms of cardiac hypertrophy by means of geometric indices derived from cardiovascular magnetic resonance","volume":"7","author":"Petersen","year":"2005","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1161\/01.CIR.97.7.666","article-title":"Functional and metabolic evaluation of the athlete\u2019s heart by magnetic resonance imaging and dobutamine stress magnetic resonance spectroscopy","volume":"97","author":"Pluim","year":"1998","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1161\/CIRCULATIONAHA.104.507723","article-title":"Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy","volume":"112","author":"Rickers","year":"2005","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0140-6736(99)06187-5","article-title":"Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopathy","volume":"355","author":"Marian","year":"2000","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/01.CIR.0000121426.43044.2B","article-title":"Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy","volume":"109","author":"Tsybouleva","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1053\/hupa.2000.16659","article-title":"Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia","volume":"31","author":"Basso","year":"2000","journal-title":"Hum Pathol"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1161\/CIRCULATIONAHA.106.657023","article-title":"Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging","volume":"115","author":"Petersen","year":"2007","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jacc.2009.04.026","article-title":"Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia","volume":"54","author":"Kwon","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1016\/j.jacc.2004.03.035","article-title":"The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy","volume":"43","author":"Moon","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB60|cit60","first-page":"923","article-title":"Delayed contrast enhancement and perfusable tissue index in hypertrophic cardiomyopathy: comparison between cardiac MRI and PET","volume":"46","author":"Knaapen","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0735-1097(98)00555-5","article-title":"Prognosis of completely asymptomatic adult patients with hypertrophic cardiomyopathy","volume":"33","author":"Takagi","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1161\/01.CIR.92.7.1680","article-title":"Hypertrophic cardiomyopathy : clinical spectrum and treatment","volume":"92","author":"Wigle","year":"1995","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1161\/01.CIR.85.5.1651","article-title":"Diversity of structural mitral valve alterations in hypertrophic cardiomyopathy","volume":"85","author":"Klues","year":"1992","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB64|cit64","first-page":"149","article-title":"Importance of leaflet elongation in causing systolic anterior motion of the mitral valve","volume":"6","author":"He","year":"1997","journal-title":"J Heart Valve Dis"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1161\/CIRCULATIONAHA.106.644682","article-title":"Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction","volume":"114","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1161\/CIRCULATIONAHA.105.583500","article-title":"Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy","volume":"114","author":"Harris","year":"2006","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1161\/CIRCULATIONAHA.108.781401","article-title":"Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy","volume":"118","author":"Maron","year":"2008","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1161\/hc4601.097997","article-title":"Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy","volume":"104","author":"Olivotto","year":"2001","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0735-1097(01)01727-2","article-title":"Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy","volume":"39","author":"Maron","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1093\/eurheartj\/ehq136","article-title":"Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy","volume":"17","author":"Melacini","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.amjcard.2004.06.024","article-title":"Determinants of atrial fibrillation development in patients with hypertrophic cardiomyopathy","volume":"94","author":"Losi","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1532-429X-11-34","article-title":"CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation","volume":"11","author":"Papavassiliu","year":"2009","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/europace\/euq013","article-title":"Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progression","volume":"12","author":"Di Donna","year":"2010","journal-title":"Europace"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1161\/01.CIR.80.5.1489","article-title":"Sudden death in hypertrophic cardiomyopathy. Assessment of patients at high risk","volume":"80","author":"McKenna","year":"1989","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/0735-1097(90)92820-R","article-title":"Relation between extent of left ventricular hypertrophy and occurrence of sudden cardiac death in hypertrophic cardiomyopathy","volume":"15","author":"Spirito","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1056\/NEJM200006153422403","article-title":"Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy","volume":"342","author":"Spirito","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.hrthm.2009.04.029","article-title":"Ventricular fibrillation in MYH7-related hypertrophic cardiomyopathy before onset of ventricular hypertrophy","volume":"6","author":"Christiaans","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM199504203321603","article-title":"Mutations in the genes for cardiac Troponin T and {alpha}-Tropomyosin in hypertrophic cardiomyopathy","volume":"332","author":"Watkins","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jacc.2007.11.071","article-title":"Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance","volume":"51","author":"Adabag","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCHEARTFAILURE.109.854026","article-title":"Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy","volume":"3","author":"Rubinshtein","year":"2010","journal-title":"Circ Heart Fail"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB81|cit81","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jama.298.4.405","article-title":"Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy","volume":"298","author":"Maron","year":"2007","journal-title":"JAMA"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB82|cit82","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0735-1097(03)00941-0","article-title":"American College of Cardiology\/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy: a report of the American College of Cardiology foundation task force on clinical expert consensus documents and the European Society of Cardiology committee for practice guidelines","volume":"42","author":"Maron","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB83|cit83","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1253\/circj.68.1035","article-title":"Acute effects of diltiazem on regional left ventricular diastolic filling dynamics in patients with hypertrophic cardiomyopathy as assessed by color kinesis","volume":"68","author":"Ito","year":"2004","journal-title":"Circ J"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB84|cit84","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/01.CIR.64.4.787","article-title":"Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy","volume":"64","author":"Bonow","year":"1981","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1161\/01.CIR.79.5.1052","article-title":"Verapamil prevents silent myocardial perfusion abnormalities during exercise in asymptomatic patients with hypertrophic cardiomyopathy","volume":"79","author":"Udelson","year":"1989","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/01.CIR.64.3.437","article-title":"Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy","volume":"64","author":"Epstein","year":"1981","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB87|cit87","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.jacc.2005.01.012","article-title":"Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy","volume":"45","author":"Sherrid","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB88|cit88","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/0002-8703(83)90259-4","article-title":"Disopyramide-induced QT prolongation and ventricular tachyarrhythmias","volume":"105","author":"Riccioni","year":"1983","journal-title":"Am Heart J"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB89|cit89","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.jacc.2004.04.063","article-title":"The case for surgery in obstructive hypertrophic cardiomyopathy","volume":"44","author":"Maron","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB90|cit90","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0140-6736(95)91267-3","article-title":"Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy","volume":"346","author":"Sigwart","year":"1995","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB91|cit91","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1161\/CIRCHEARTFAILURE.109.862359","article-title":"Long-term outcome of alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: a word of caution","volume":"3","author":"ten Cate","year":"2010","journal-title":"Circ Heart Fail"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB92|cit92","doi-asserted-by":"crossref","first-page":"53H","DOI":"10.1016\/S0002-9149(99)00259-3","article-title":"Role of the renin-angiotensin system in cardiac hypertrophy","volume":"83","author":"Yamazaki","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB93|cit93","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1161\/01.CIR.103.6.789","article-title":"Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy","volume":"103","author":"Lim","year":"2001","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB94|cit94","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1253\/circj.69.1244","article-title":"Valsartan decreases type I collagen synthesis in patients with hypertrophic cardiomyopathy","volume":"69","author":"Kawano","year":"2005","journal-title":"Circ J"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB95|cit95","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1536\/ihj.48.715","article-title":"A new therapeutic strategy for hypertrophic nonobstructive cardiomyopathy in humans: a randomized and prospective study with an angiotensin II receptor blocker","volume":"48","author":"Yamazaki","year":"2007","journal-title":"Int Heart J"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB96|cit96","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2353\/jmoldx.2009.080082","article-title":"The effects of candesartan on left ventricular hypertrophy and function in nonobstructive hypertrophic cardiomyopathy: a pilot, randomized study","volume":"11","author":"Penicka","year":"2009","journal-title":"J Mol Diagn"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB97|cit97","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1161\/hc2801.094031","article-title":"Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy","volume":"104","author":"Patel","year":"2001","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB98|cit98","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1172\/JCI200214677","article-title":"The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model","volume":"109","author":"Semsarian","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB99|cit99","first-page":"3893","article-title":"Myofilament Ca2+ sensitization causes susceptibility to cardiac arrhythmia in mice","volume":"118","author":"Baudenbacher","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB100|cit100","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.RES.86.5.580","article-title":"The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase","volume":"86","author":"Kantor","year":"2000","journal-title":"Circ Res"},{"key":"10.1111\/j.1365-2362.2010.02439.x-BIB101|cit101","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00259-009-1350-3","article-title":"Determinants of myocardial energetics and efficiency in symptomatic hypertrophic cardiomyopathy","volume":"37","author":"Timmer","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2362.2010.02439.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2362.2010.02439.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T00:24:13Z","timestamp":1625358253000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2362.2010.02439.x"}},"subtitle":["PATHOGENESIS OF HYPERTROPHIC CARDIOMYOPATHY"],"short-title":[],"issued":{"date-parts":[[2010,12,15]]},"references-count":101,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2362.2010.02439.x","relation":{},"ISSN":["0014-2972"],"issn-type":[{"value":"0014-2972","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12,15]]}}}